Needlestick injuries (NSIs) may potentially expose healthcare professionals (HCPs) to bloodborne pathogens. Safety needles are designed to protect against NSIs. We evaluated whether a new fully passive safety needle could be used safely by HCPs. The passive safety needle was tested by physicians, nurses, and pharmacists in subcutaneous or intramuscular injection scenarios in simulation studies (1–3). Data collected included successes, close calls, difficulties, use errors, and failures. In study 4, HCPs rated the device safety (21-item questionnaire). Results Overall, 104 participants completed 4772 simulated tasks, including 932 injections. 915 injections (98.18%) were performed successfully and no NSIs (0%) were observed…more

In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of individuals that can benefit from the available vaccine vials. The MTD Group, leveraging its Research Hub located in Como (Italy), with its decades of experience in designing and producing needles and syringes, has made investments to take part in the global effort to supply products that will minimize vaccine waste, and help to accelerate the COVID-19 vaccination effort according to the above recommendations. For more information see the full communication: Low Dead Space Syringesmore